Treatment

DT-DEC01 clinical trials

1 indexed studies · 0 currently recruiting

AuthorisedPhase I and Phase II (Integrated)- First administration to humans
A PHASE 1/2, OPEN-LABEL, EXPLORATORY CLINICAL TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF DT-DEC01 THERAPY IN PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY
This study is testing a new treatment, DT-DEC01, for Duchenne Muscular Dystrophy. It aims to see if it's safe and how well it helps improve muscle function in both patients who can walk and those who can't.
For: Duchenne Muscular Dystrophy
Poland